GSK wins as weak pound provides windfall
GlaxoSmithKline has beaten quarterly sales and profit expectations and said it expects even bigger gains in 2016. As Laura Frykberg reports, it's all thanks to a weak pound, which has continued to fall after Britain's vote in June to leave the European Union.
